Segmentation by type further refines the market taxonomy into distinct tube configurations: Nasogastric (NG), Nasojejunal (NJ), Orogastric (OG), Orojejunal (OJ), and Trans‑esophageal variants. Nasogastric tubes, the most widely used, capture the largest share due to ease of insertion and suitability for short‑term feeding, typically up to four weeks. Nasojejunal tubes, comprising about 20% of type‑specific sales, are preferred for patients at high risk of aspiration, offering distal placement into the jejunum. Orogastric devices serve pediatric populations where nasal routes are unsuitable, contributing a niche yet stable demand. Orojejunal tubes, less common, address specialized clinical protocols requiring jejunal access via the oral cavity. Trans‑esophageal systems, emerging in critical‑care settings, provide a minimally disruptive alternative for patients with obstructed nasal passages. The relative contribution of each type reflects procedural complexity, duration of therapy, and patient‑specific anatomical considerations, collectively defining the overall market size for non‑invasive feeding tubes.